Search results
BioMarin (BMRN) Posts Q4 Earnings Beat, Upbeat Voxzogo Sales
Zacks via Yahoo Finance· 3 months agoBioMarin Pharmaceutical BMRN reported fourth-quarter 2023 adjusted earnings per share of 49 cents,...
BioMarin (BMRN) Q2 Earnings & Sales Top, Voxzogo Drives Sales
Zacks via Yahoo Finance· 10 months agoBioMarin Pharmaceutical BMRN reported second-quarter 2023 adjusted earnings per share of 54 cents,...
BioMarin (BMRN) Stock Jumps 5.4%: Will It Continue to Soar?
Zacks via Yahoo Finance· 2 years agoBioMarin (BMRN) was a big mover last session on higher-than-average trading volume. The latest trend...
An Intrinsic Calculation For BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Suggests It's 45%...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights The projected fair value for BioMarin Pharmaceutical is US$166 based on 2 Stage Free...
Biotech Stock Roundup: BMRN's Gene Therapy Gets Approval, SGTX Up on Buyout by LLY
Zacks via Yahoo Finance· 11 months agoIt was a busy week for the biotech sector with many important regulatory and pipeline updates. Among...
BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks via Yahoo Finance· 2 years agoBioMarin (BMRN) possesses the right combination of the two key ingredients for a likely earnings...
Here's Why Investors May Bet on BioMarin (BMRN) Stock Now
Zacks via Yahoo Finance· 4 months agoBioMarin Pharmaceutical Inc. BMRN develops treatments for serious life-threatening medical...
Biotech/Drug Stocks Q4 Earnings Due Feb 22: MRNA, BHC, NTLA, BMRN & More
Zacks via Yahoo Finance· 3 months agoWe are in the last leg of the fourth-quarter 2023 reporting cycle and a lot of pharma and biotech...
Is the Options Market Predicting a Spike in BioMarin Pharmaceutical (BMRN) Stock?
Zacks via Yahoo Finance· 1 year agoInvestors in BioMarin Pharmaceutical Inc. BMRN need to pay close attention to the stock based on...
BioMarin (BMRN) Q3 Earnings Beat, Sales Miss, Ups Voxzogo View
Zacks via Yahoo Finance· 2 years agoBioMarin Pharmaceutical BMRN reported adjusted earnings of 45 cents per share in third-quarter 2022,...